Welcome to our dedicated page for Wrap Technologies SEC filings (Ticker: WRAP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Wrap Technologies, Inc. (Nasdaq: WRAP) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-assisted summaries to help interpret complex documents. As a Delaware corporation in the non-lethal public safety technology and manufacturing space, Wrap files a range of forms that shed light on its capital structure, governance, and strategic initiatives around products such as the BolaWrap 150, WrapReality VR, WrapVision body-worn camera system, WrapTactics training programs, and CUAS solutions like PAN-DA and MERLIN-Interdictor.
Through Forms 10-K and 10-Q, investors can review Wrap’s audited and quarterly financial statements, risk factors, and management discussion of its non-lethal response ecosystem, subscription offerings like WrapReady and WrapPlus, and investments in research and development. Current reports on Form 8-K detail material events, including private placements of Series B Convertible Preferred Stock and accompanying warrants, amendments to the Amended and Restated Certificate of Incorporation to increase authorized common shares, changes to bylaws governing stockholder voting standards, executive transitions, and updates on equity compensation plans.
Proxy materials such as the DEF 14A definitive proxy statement provide information on board elections, share authorization proposals, reverse stock split authority, and incentive plan amendments. These documents outline how the company seeks stockholder approval for actions that affect existing and potential WRAP shareholders.
On Stock Titan, AI-powered tools highlight key points from lengthy filings, explain technical terms, and surface items related to equity issuance, voting rights, and compensation plans. Users can quickly identify disclosures about preferred stock designations, warrant terms, registration rights agreements, and other capital markets activities. The filings page also links to any reported insider-related information contained in these documents, helping investors understand how governance and financing decisions intersect with Wrap’s strategy in non-lethal public safety, training, and counter-UAS technologies.
WRAP Technologies Executive Chairman and CEO Scot Cohen reported stock acquisitions on Form 4. On March 4, 2026, an entity called V4 Global LLC received 38,740 shares of common stock, issued as a dividend payment on Series A Convertible Preferred Stock. These securities are directly owned by V4 Global LLC and may be deemed beneficially owned by Cohen as its managing member, although he disclaims beneficial ownership except for his pecuniary interest.
On the same date, Cohen also reported a separate grant or award acquisition of 27,672 shares of common stock held directly. After this direct transaction, his direct holdings totaled 6,559,837 shares of common stock.
Scot Cohen filed Amendment No. 2 to his Schedule 13D reporting beneficial ownership of 17,835,611 WRAP Technologies common shares, or 27.3% of the class. This total includes common stock, vested stock options, RSUs, convertible Series A and B preferred shares, and warrants held directly and through entities V4 Global LLC and the Scot Cohen Roth IRA.
The amendment details additional shares and warrants obtained via dividends on preferred stock, option grants under the 2017 Equity Compensation Plan, and private placements. V4 Global acquired Series B preferred stock, common shares, and warrants under August 2025 and February 2026 Securities Purchase Agreements, with related registration rights for resale of the underlying common shares.
Wrap Technologies, Inc. is registering up to 5,000,000 shares of common stock for resale by existing investors, made up of 1,700,000 already-issued shares, 2,500,000 shares underlying common warrants, and 800,000 shares underlying pre-funded warrants, all from a February 2026 private placement.
The company previously raised approximately $5.0 million in gross proceeds in that private deal. It will not receive any cash from resale of these shares, but could receive additional funds if investors exercise common warrants at $2.30 per share. The warrants are immediately exercisable and common warrants expire five years after issuance. A 4.99% (or, at holder election, 9.99%) beneficial ownership cap limits how many shares each holder can own after exercise.
As of February 6, 2026, Wrap had 54,501,638 common shares outstanding, and issuing all shares covered by this prospectus would add about 9.17% to that count. The filing warns that resale of a large block of shares, together with anti-dilution features in the warrants, could pressure the stock price and dilute existing shareholders. Wrap’s stock trades on Nasdaq under the symbol WRAP, and the closing price on February 12, 2026 was $1.70 per share, below the common warrant exercise price.
Wrap Technologies received a Schedule 13G from Iroquois Capital Management, Richard Abbe and Kimberly Page reporting a significant passive stake. Collectively, the reporting persons beneficially owned 4,425,830 shares of common stock, or 7.6% of the company’s outstanding shares as of February 3, 2026.
The position includes common stock plus shares issuable from Series A and Series B convertible preferred stock, warrants and pre-funded warrants, all subject to 4.99% and 9.99% beneficial ownership blockers that limit how much can be converted or exercised at any time. The filers certify the holdings are not for the purpose of changing or influencing control of the company.
Wrap Technologies, Inc. is registering 5,000,000 shares of common stock for resale by existing investors under a shelf registration statement. The shares include 1,700,000 already-issued common shares, 2,500,000 shares underlying common warrants and 800,000 shares underlying pre-funded warrants issued in a February 2026 private placement.
The company previously raised approximately $5.0 million of gross proceeds in that private placement. It will not receive proceeds from investors’ resale of these shares, but would receive cash only if the $2.30-per-share common warrants are exercised. As of February 6, 2026, 54,501,638 shares were outstanding; full issuance of the registered shares would equal about 9.17% of that amount, which the company highlights as a potential dilution and stock overhang risk.
Wrap Technologies, Inc. entered into a securities purchase agreement for a private placement of equity and warrants. The deal includes 1,700,000 common shares, pre-funded warrants to buy up to 800,000 shares at an exercise price of $0.0001, and common warrants to buy up to 2,500,000 shares at $2.30 per share. Investors paid $2.00 for each common share and accompanying common warrant, and $1.9999 for each pre-funded warrant and accompanying common warrant. The transaction closed on February 3, 2026 and generated approximately $5 million in gross proceeds, which the company plans to use for general corporate purposes and working capital. The securities were issued in an unregistered private offering under Section 4(a)(2) and Regulation D, with registration rights for resale of the shares and warrant shares.
Wrap Technologies Executive Chairman and CEO Scot Cohen, also a director and 10% owner, reported multiple equity transactions. Through V4 Global LLC, an entity associated with him, 475,000 shares of common stock were purchased from Wrap Technologies at $2 per share in a private placement, and 60,345 additional shares were issued as stock dividends on Series A Convertible Preferred Stock. Cohen also received 43,104 dividend shares directly.
Separately, a Roth IRA associated with Cohen acquired 475,000 PIPE warrants exercisable for common stock at $2.30 per share, subject to adjustment. Cohen was also granted 2,000,000 stock options with an exercise price of $2.18 per share, 25% vesting on the grant date and the remainder vesting annually over three years, with potential accelerated vesting if specified market capitalization milestones are achieved while he continues in service.
WRAP Technologies granted President and COO Jared Novick stock options to buy 1,000,000 shares of common stock at an exercise price of $2.18 per share on 02/01/2026.
The options expire on 02/01/2036. According to the terms, 25% of the options vested immediately on the grant date, and the remaining 75% will vest in three equal annual installments. Unvested options may vest faster if certain market capitalization milestones are achieved, but in all cases Novick must be employed or providing services to WRAP on each applicable vesting date.
Wrap Technologies director Bruce Bernstein reported a new stock option grant. On February 1, 2026, he received a stock option to buy 100,000 shares of Wrap Technologies common stock at an exercise price of $2.18 per share, expiring on February 1, 2036.
According to the filing, 33,000 options vested immediately on the grant date. The remaining options will vest in three equal annual tranches, as long as Bernstein continues to be employed by or provide services to the company on each vesting date. After this grant, he beneficially owns 100,000 derivative securities directly.
Juggernaut Management, LLC, an entity associated with WRAP director John D. Shulman, acquired 250,000 shares of common stock at $2.00 per share and 250,000 warrants with a $2.30 exercise price in a private placement on February 2, 2026.
The warrants can be exercised into 250,000 WRAP common shares and their exercise price is adjustable if the company issues stock or convertible securities below $2.30. Following these transactions, Shulman also directly owned 79,394 WRAP common shares.